Literature DB >> 35020891

Kidney infiltrating NK cells and NK-like T-cells in lupus nephritis: presence, localization, and the effect of immunosuppressive treatment.

Andrea Scheffschick1, Sina Fuchs1, Vivianne Malmström1, Iva Gunnarsson1,2, Hanna Brauner1,3.   

Abstract

Systemic lupus erythematosus (SLE) is a multi-organ inflammatory disease with kidney inflammation, lupus nephritis (LN), being one of the most severe manifestations. Immune complex deposits, particularly in glomeruli, and T cells, B cells, and myeloid cells, mainly with extraglomerular localization, contribute to the inflammatory process. Natural killer (NK) cells have been suggested to play a role in autoimmune diseases, but have not been investigated in detail in renal lupus before. In this exploratory study, we performed the first characterization of NK cell number and distribution in LN kidney biopsies. Twelve SLE patients were analyzed in the active phase of disease and five patients following immunosuppressive therapy. CD56+ cells, corresponding to NK cells or NK-like T-cells, were identified in all patients; however, with reduced numbers in four out of five patients at follow-up. Furthermore, cells were present in the kidney interstitium and peri-glomerular areas, but only rarely in glomeruli. Fluorescent co-staining of CD56 or NKp46 and CD3 revealed the presence of both CD56+/NKp46+CD3-NK cells and CD56+/NKp46+CD3+NK-like T-cells. Compared to healthy kidney sections, one out of four LN patients showed increased numbers of NK cells. A correlation between CD56+ and NK cells with clinical parameters could not be observed, perhaps due to the small patient cohort. In conclusion, we have identified NK cells and NK-like T-cells in the LN kidney and performed the first detailed analysis of their localization during active and inactive diseases. Their role in LN pathogenesis is, however, unclear and deserves further studies.
© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Immunology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  CD56; NK cells; NK-like T-cells; NKp46; glomerulonephritis; lupus nephritis; systemic lupus erythematosus

Mesh:

Substances:

Year:  2022        PMID: 35020891      PMCID: PMC8982963          DOI: 10.1093/cei/uxab035

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Manifestations of systemic lupus erythematosus.

Authors:  Manole Cojocaru; Inimioara Mihaela Cojocaru; Isabela Silosi; Camelia Doina Vrabie
Journal:  Maedica (Buchar)       Date:  2011-10

2.  NKG2D ligand overexpression in lupus nephritis correlates with increased NK cell activity and differentiation in kidneys but not in the periphery.

Authors:  Roberto Spada; José M Rojas; Sonia Pérez-Yagüe; Vladimir Mulens; Pablo Cannata-Ortiz; Rafael Bragado; Domingo F Barber
Journal:  J Leukoc Biol       Date:  2015-01-12       Impact factor: 4.962

3.  Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs.

Authors:  H A Austin; J H Klippel; J E Balow; N G le Riche; A D Steinberg; P H Plotz; J L Decker
Journal:  N Engl J Med       Date:  1986-03-06       Impact factor: 91.245

Review 4.  Update on Lupus Nephritis: Core Curriculum 2020.

Authors:  Samir V Parikh; Salem Almaani; Sergey Brodsky; Brad H Rovin
Journal:  Am J Kidney Dis       Date:  2020-03-24       Impact factor: 8.860

5.  Long-term administration of IgG2a anti-NK1.1 monoclonal antibody ameliorates lupus-like disease in NZB/W mice in spite of an early worsening induced by an IgG2a-dependent BAFF/BLyS production.

Authors:  Edilberto Postól; André Meyer; Fabíola Cardillo; Raquel de Alencar; Daniel Pessina; Jorge Nihei; Mário Mariano; José Mengel
Journal:  Immunology       Date:  2008-04-07       Impact factor: 7.397

6.  Activated natural killer T cells in mice induce acute kidney injury with hematuria through possibly common mechanisms shared by human CD56+ T cells.

Authors:  Takahiro Uchida; Hiroyuki Nakashima; Seigo Ito; Takuya Ishikiriyama; Masahiro Nakashima; Shuhji Seki; Hiroo Kumagai; Naoki Oshima
Journal:  Am J Physiol Renal Physiol       Date:  2018-07-11

Review 7.  Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression.

Authors:  Anadi Mahajan; Justyna Amelio; Kerry Gairy; Gavneet Kaur; Roger A Levy; David Roth; Damon Bass
Journal:  Lupus       Date:  2020-06-22       Impact factor: 2.911

Review 8.  Natural Killer Cells: Development, Maturation, and Clinical Utilization.

Authors:  Alex M Abel; Chao Yang; Monica S Thakar; Subramaniam Malarkannan
Journal:  Front Immunol       Date:  2018-08-13       Impact factor: 7.561

9.  NKp46 Clusters at the Immune Synapse and Regulates NK Cell Polarization.

Authors:  Uzi Hadad; Timothy J Thauland; Olivia M Martinez; Manish J Butte; Angel Porgador; Sheri M Krams
Journal:  Front Immunol       Date:  2015-09-25       Impact factor: 7.561

Review 10.  Towards Precision Medicine in Systemic Lupus Erythematosus.

Authors:  Elliott Lever; Marta R Alves; David A Isenberg
Journal:  Pharmgenomics Pers Med       Date:  2020-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.